Results 191 to 200 of about 4,742,503 (345)

International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013.

Journal of the National Cancer Institute, 2018
J. Lortet-Tieulent, J. Ferlay, F. Bray, A. Jemal   +3 more
semanticscholar   +1 more source

Cancer of the vulva: 2025 update

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development.
Alexander B. Olawaiye, Mauricio A. Cuello, Sushil Beriwal, Linda J. Rogers   +3 more
wiley   +1 more source

Increased Circulating Levels of Insulin-Like Growth Factor-I and Decreased Circulating Levels of Insulin-Like Growth Factor Binding Protein-1 in Postmenopausal Women with Endometrial Cancer.

, 1997
Takuya Ayabe, Osamu Tsutsumi, Hideaki Sakai, Hiroyuki Yoshikawa, Tetsu Yano, Fumihiko Kurimoto, Yuji Taketani   +6 more
openalex   +2 more sources

Clinical differences between adipose‐ and muscle‐layer cesarean scar endometriosis: A retrospective observational study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background/aim This study evaluated cesarean section scar endometriosis (CSSE) characteristics and compared adipose‐ and muscle‐layer CSSEs. Materials and methods We analyzed 53 patients who underwent CSSE surgery between 2019‐2024, with 38 (71.7%) having adipose‐layer and 15 (28.3%) having muscle‐layer CSSE.
Emre Erdem Taş, Mohammad İbrahim Halilzade, Melike Doğanay, Ayse Filiz Yavuz   +3 more
wiley   +1 more source

Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials [PDF]

, 2017
et al,, Mutch, David G
core   +1 more source

Continuous Low-Dose Combined Hormone Replacement Therapy and the Risk of Endometrial Cancer

, 1997
John T. Comerci, Abbie L. Fields, Carolyn D. Runowicz, Gary L. Goldberg   +3 more
openalex   +1 more source

Inhibition of Vascular Endothelial Growth Factor Expression in HEC1A Endometrial Cancer Cells through Interactions of Estrogen Receptor α and Sp3 Proteins [PDF]

, 2000
Matthew Stoner, Fan Wang, Mark Wormke, Thu Annelise Nguyen, Ismael Samudio, Carrie A. Vyhlidal, Dieter Marmé, Günter Finkenzeller, Stephen Safe   +8 more
openalex   +1 more source

Dienogest use and the risk of breast and gynecologic cancers: A nationwide population‐based study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To evaluate whether dienogest exposure is associated with the risk of breast, endometrial, or tubo‐ovarian cancer in women with endometriosis. Methods In this nationwide retrospective cohort study (January 2012 to December 2023), we used the Korean National Health Insurance Review & Assessment Service database. Women aged 20–49 years
Hoyol Jhang, Saerom Kim, Hyun‐Tae Park, Ju‐Young Shin, Seung‐Ah Choe   +4 more
wiley   +1 more source

The prognostic value of CD44 isoform expression in endometrial cancer

, 1998
Clemens Tempfer, G. Haeusler, Alexandra Kaider, Lukas Hefler, E. Hanzal, Alexander Reinthaller, G. Breitenecker, Christian Kainz   +7 more
openalex   +1 more source

Tamoxifen induces endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia [PDF]

, 2000
P. Carthew, Richard Edwards, Barbara Nolan, Elizabeth A. Martin, Robert Heydon, Ian N.H. White, Mary J. Tucker   +6 more
openalex   +1 more source